|
New Zenith Clinical Trial Listing: ZEN003694 and Nivolumab w/ or w/o Ipilimumab in Solid Tumors
|
10
|
Zenith Epigenetics
|
Apr 23, 2021 08:04AM
|
|
Re: ZEN-3694 and Enzalutamide 2b Trial
|
7
|
Zenith Epigenetics
|
Apr 23, 2021 07:56AM
|
|
Re: Zenith Epigenetics Announces Clinical Collaboration with Astellas
|
3
|
Zenith Epigenetics
|
Apr 22, 2021 04:34PM
|
|
Zenith Epigenetics Announces Clinical Collaboration with Astellas
|
8
|
Zenith Epigenetics
|
Apr 22, 2021 04:34PM
|
|
Re: ZEN-3694 and Enzalutamide 2b Trial
|
6
|
Zenith Epigenetics
|
Apr 22, 2021 04:31PM
|
|
Another apabetalone/COVID-19 connection
|
8
|
Resverlogix Corp.
|
Apr 20, 2021 05:39PM
|
|
Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
10
|
Resverlogix Corp.
|
Apr 20, 2021 08:08AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
18
|
Resverlogix Corp.
|
Apr 12, 2021 12:56PM
|
|
Re: Zenith Presentation at AACR Meeting April 10-15
|
3
|
Zenith Epigenetics
|
Apr 12, 2021 11:12AM
|
|
Zenith upcoming events
|
5
|
Zenith Epigenetics
|
Apr 12, 2021 11:10AM
|
|
Re: A few upcoming conference appearances
|
8
|
Resverlogix Corp.
|
Apr 12, 2021 11:07AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
3
|
Resverlogix Corp.
|
Apr 12, 2021 10:54AM
|
|
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
7
|
Resverlogix Corp.
|
Apr 12, 2021 10:54AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
7
|
Resverlogix Corp.
|
Apr 12, 2021 10:49AM
|
|
Zenith Presentation at AACR Meeting April 10-15
|
4
|
Zenith Epigenetics
|
Apr 09, 2021 02:43PM
|
|
Re: Clinical trials query results
|
5
|
Zenith Epigenetics
|
Apr 08, 2021 01:10PM
|
|
Re: GV on stock house
|
8
|
Resverlogix Corp.
|
Apr 08, 2021 01:05PM
|
|
Re: Clinical trials query results
|
6
|
Zenith Epigenetics
|
Apr 08, 2021 01:03PM
|
|
Re: A few upcoming conference appearances
|
6
|
Resverlogix Corp.
|
Apr 02, 2021 04:44PM
|
|
Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
4
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 05:21PM
|
